iRhythm Technologies, Inc. (IRTC)
NASDAQ • Healthcare
Last close at September 16, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 29
in 43 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
iRhythm’s preliminary second fiscal quarter of 2026 results showed revenue topping consensus, with sales rising 20.1% year over year to about $224.2 million (up from $186.7 million a year ago) and coming in above expectations at $224.2 million versus a $219.3 million estimate (+2.2%), as reported August 6, 2026. Profitability remained high at the gross line, with gross margin at roughly 73% on gross profit of about $163.2 million, while operating results were slightly negative, with operating margin at around -1% and operating income of roughly -$2.5 million. Cash generation was positive, with operating cash flow of about $51.1 million for the quarter. For the next period, consensus calls for EPS of $0.02 on revenue of $222.4 million.
About iRhythm Technologies, Inc.
iRhythm Technologies, Inc., listed on the NASDAQ as IRTC, develops and provides portable electrocardiogram monitoring solutions for the healthcare sector in the United States. The company generated $747.1 million of revenue in FY2025 through wearable biosensors and related monitoring services for rhythm assessment.
Today's Snapshot
IRTC ended the day slightly lower at 111.82, in line with a flat sector.
Trading Volume
Below 10d avg (546.2K)
479.6K
vs S&P 500 Today
Outperforming Market
+0.53%
Updated: September 16, 2026 at 20:23 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$115.84 - $136.14Sell
- RSI (14)40.03Neutral
- Stochastic %K (14, 3, 3)16.65Buy
- MACD Level (12, 26)-2.06Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.